Author

Lauriola M

Univerisity of Bologna - Cited by 2,338

Biography

Lauriola M is from Department of Biological Regulation, Weizmann Institute of Science, Rehovot, 76100, Israel and has research interest in endocrinology, hormone, bio science, medical science and clinical science.
Title
Cited by
Year
Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor
Y Enuka, M Lauriola, ME Feldman, A Sas-Chen, I Ulitsky, Y YardenNucleic acids research 44 (3), 1370-1383, 2016201
472
2016
Roles of IL-1 in cancer: from tumor progression to resistance to targeted therapies
V Gelfo, D Romaniello, M Mazzeschi, M Sgarzi, G Grilli, A Morselli, ...International journal of molecular sciences 21 (17), 6009, 2020202
72
2020
Adenomatous polyposis coli (APC) regulates miR17-92 cluster through β-catenin pathway in colorectal cancer
Y Li, M Lauriola, D Kim, M Francesconi, G D’Uva, D Shibata, MP Malafa, ...Oncogene 35 (35), 4558-4568, 2016201
53
2016
Estrogen receptors and melanoma: a review
E Dika, A Patrizi, M Lambertini, N Manuelpillai, M Fiorentino, A Altimari, ...Cells 8 (11), 1463, 2019201
45
2019
Systematic large-scale meta-analysis identifies a panel of two mRNAs as blood biomarkers for colorectal cancer detection
MT Rodia, G Ugolini, G Mattei, I Montroni, D Zattoni, F Ghignone, ...Oncotarget 7 (21), 30295, 2016201
45
2016
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumors
L Roth, S Srivastava, M Lindzen, A Sas-Chen, M Sheffer, M Lauriola, ...Science signaling 11 (515), eaan0949, 2018201
45
2018
The roadmap of colorectal cancer screening
E Ferlizza, R Solmi, M Sgarzi, L Ricciardiello, M LauriolaCancers 13 (5), 1101, 2021202
27
2021
A novel role for the interleukin-1 receptor axis in resistance to anti-EGFR therapy
V Gelfo, M Mazzeschi, G Grilli, M Lindzen, S Santi, G D’uva, B Győrffy, ...Cancers 10 (10), 355, 2018201
26
2018
LGALS4, CEACAM6, TSPAN8, and COL1A2: Blood markers for colorectal cancer—validation in a cohort of subjects with positive fecal immunochemical test result
MT Rodia, R Solmi, F Pasini, E Nardi, G Mattei, G Ugolini, L Ricciardiello, ...Clinical Colorectal Cancer 17 (2), e217-e228, 2018201
26
2018
Towards the emerging crosstalk: ERBB family and steroid hormones
G D’Uva, M LauriolaSeminars in cell & developmental biology 50, 143-152, 2016201
25
2016
Cardiotoxicity of anticancer drugs: molecular mechanisms and strategies for cardioprotection
MB Morelli, C Bongiovanni, S Da Pra, C Miano, F Sacchi, M Lauriola, ...Frontiers in Cardiovascular Medicine 9, 847012, 202
22
2022
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone
Y Enuka, ME Feldman, A Chowdhury, S Srivastava, M Lindzen, ...Nucleic acids research 45 (22), 12681-12699, 2017201
21
2017
Colorectal cancer screening: Assessment of CEACAM6, LGALS4, TSPAN8 and COL1A2 as blood markers in faecal immunochemical test negative subjects
E Ferlizza, R Solmi, R Miglio, E Nardi, G Mattei, M Sgarzi, M LauriolaJournal of Advanced Research 24, 99-107, 2020202
17
2020
ETS proteins bind with glucocorticoid receptors: relevance for treatment of Ewing sarcoma
S Srivastava, NB Nataraj, A Sekar, S Ghosh, C Bornstein, D Drago-Garcia, ...Cell Reports 29 (1), 104-1. e4, 2019201
17
2019
Human trisomy 21 fibroblasts rescue methotrexate toxic effect after treatment with 5‐methyl‐tetrahydrofolate and 5‐formyl‐tetrahydrofolate
L Vitale, V Serpieri, M Lauriola, A Piovesan, F Antonaros, E Cicchini, ...Journal of Cellular Physiology 234 (9), 15010-15024, 2019201
11
2019
AXL and error-prone DNA replication confer drug resistance and offer strategies to treat EGFR-mutant lung cancer
A Noronha, N Belugali Nataraj, JS Lee, B Zhitomirsky, Y Oren, S Oster, ...Cancer discovery 12 (11), 2666-2683, 2022202
10
2022
Glucocorticoid receptor antagonization propels endogenous cardiomyocyte proliferation and cardiac regeneration
N Pianca, F Sacchi, KB Umansky, M Chirivì, L Iommarini, S Da Pra, ...Nature Cardiovascular Research 1 (7), 617-633, 2022202
8
2022
Glucocorticoid receptor modulates EGFR feedback upon acquisition of resistance to monoclonal antibodies
V Gelfo, F Pontis, M Mazzeschi, M Sgarzi, M Mazzarini, R Solmi, G D’Uva, ...Journal of Clinical Medicine (5), 600, 2019201
8
2019
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer
M Mazzeschi, M Sgarzi, D Romaniello, V Gelfo, C Cavallo, F Ambrosi, ...Journal of Experimental & Clinical Cancer Research 41 (1), 1-18, 2022202
6
2022
Glucocorticoid Receptor ablation promotes cardiac regeneration by hampering cardiomyocyte terminal differentiation
N Pianca, F Pontis, M Chirivì, V Papa, L Braga, RS Patnala, ...bioRxiv, 2020.01. 1.901249, 2020202
5
2020

Referred From: https://scholar.google.com/citations?user=vPMcU4sAAAAJ&hl=en

Cited by
Citations 2338
h-index 25
i10-index 36
Open Access Journals